Skip to main content

Table 1 Baseline characteristics of the study population

From: Transfer between hospitals as a predictor of delay in diagnosis and treatment of patients with Non-Small Cell Lung Cancer – a register based cohort-study

  No transfer (%) Transfer (%) Total (%) P-value
N 4434 6839 11,273
Agea <68 2068 (46.64) 3275 (47.89) 5343 (47.40) 0.198
> = 68 2366 (53.36) 3564 (52.11) 5930 (52.60)
Sex Male 2299 (51.85) 3548 (51.88) 5847 (51.87) 0.976
Female 2135 (48.15) 3291 (48.12) 5426 (48.13)
Stage 0, I, II, IIIa 1611 (36.33) 3450 (50.48) 5061 (44.89) <0.000
IIIb, IV 2799 (63.13) 3347 (48.94) 6146 (54.52)
Missing 24 (0.54) 42 (0.61) 66 (0.59)
Co-morbidity (CCI) 0 2333 (52.62) 3479 (50.87) 5812 (51.56) 0.156
1 1829 (41.25) 2904 (42.46) 4722 (41.99)
>1 272 (6.13) 456 (6.67) 728 (6.46)
Treatment Curative 1287 (29.03) 3435 (50.08) 4712 (41.80) <0.000
Palliative 3147 (70.97) 3414 (49.92) 6561 (58.20)
ECOG 0 1618 (36.49) 3068 (44.86) 4686 (41.57) <0.000
1 1705 (38.45) 2299 (33.62) 4004 (35.52)
>1 1111 (25.06) 1472 (21.52) 2583 (22.91)
Year 2008 1259 (37.24) 747 (62.76) 2006 (100) <0.000
2009 1408 (33.65) 714 (66.35) 2122 (100)
2010 1452 (37.09) 856 (62.91) 2308 (100)
2011 1504 (40.48) 1023 (59.52) 2527 (100)
2012 1216 (47.36) 1094 (52.64) 2310 (100)
FEV1 N (Mean, sd) 3842 (1.83,0.85) 6363 (1.96, 0.89) 10,205 (1.91,0.87) <0.000
Days from referral to treatment Mean(sd) 35.59 (14.58) 40.19 (15.68) 38.38 (15.42) <0.000
Days from referral to diagnosis Mean (sd) 20.26 (11.59) 22.26 (12.43) 21.47 (12.13) <0.000
Days from diagnosis to treatment Mean (sd) 15.33 (9.70) 17.93 (11.09) 16.91 (10.64) <0.000
  1. a68 is the mean age of the patient population